Evidence map›Paper›PMID 29552095›Full record

ArticleJournal of infection prevention2018

Kordo Saeed, Christina Petridou, Hazel Gray, Matthew Dryden, Karen Davis-Blues, Sheryl Lucero, Natalie Parker, Taryn Keyser, Tanya Matthews, Nick Cortes and 5 more

Abstract read
In one paragraph

Article in Journal of infection prevention, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. RethinkingEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024
    Article
  2. Journal of infection prevention · 2018
    Article
  3. Root cause analysis forJournal of infection prevention · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Kordo SaeedMicrobiology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Christina PetridouMicrobiology, Queen Alexandra Hospital, Portsmouth, UK.
Hazel GrayInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Matthew DrydenMicrobiology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Karen Davis-BluesInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Sheryl LuceroInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Natalie ParkerPharmacy, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Taryn KeyserPharmacy, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Tanya MatthewsInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Nick CortesMicrobiology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Stephen KiddMicrobiology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Claire ThomasMicrobiology, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Heather PeacockInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Joanna HornzeeInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.
Bruce WakeInfection Control, Hampshire Hospitals NHS Foundation Trust, Basingstoke and Winchester, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn Hampshire Hospitals NHS Foundation Trust, in addition to an on-the-spot investigation into hospital-onset METHODOLOGY: Over two years, 84 cases of hospital-onset CDI cases were reviewed by the MDT-RCA forum.

resultsAmong this cohort, no additional learning outcomes were identified by the MDT-RCAs over those that were found by on-the-spot investigations. In total, 543 staff members attended the MDT-RCAs at a potential cost to the Trust of £23,795.74-£51,670.10. The Trust appealed against financial penalties for 27 cases and 14 were successful, i.e. £140,000 would have been avoided had targets been breached by 14 cases. However, targets were only breached by two cases, meaning only £20,000 in fines was avoided. Deducting this from the total costs of the MDT-RCA meant the Trust lost £3,795.74-£31,670.10.

conclusionOver the two years reviewed, the MDT-RCA proved to be costly to the Trust, with no additional learning or quality improvement measures identified.

Indexed as

clinical commissioning groupClostridium difficileClostridium difficile infectionroot cause analysis

Identifiers

PMID29552095
PMCPMC5846979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.